KDU-731

N/A

Report date: 2025/11/26 20:00:44
NME

Base Information

Drug NameKDU-731
Drug Alias NameEDI-048KDU-731ABO-809
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphatidylinositol 4-kinase inhibitors
TargetsPhosphatidylinositol 4-kinase
Therapy Area/IndicationsCryptosporidiosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of GeorgiaWashington State UniversityNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsCryptosporidiosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A